Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEUCRAVACITINIB vs DEUTETRABENAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEUCRAVACITINIB vs DEUTETRABENAZINE: Safety Overview

Metric DEUCRAVACITINIB DEUTETRABENAZINE
Total FAERS Reports 2,386 5,849
Deaths Reported 36 411
Death Rate 1.5% 7.0%
Hospitalizations 121 704
Average Patient Age 56.8 yrs 61.3 yrs
% Female Patients 63.8% 67.5%
FDA Approval Date Sep 9, 2022 Apr 3, 2017
Manufacturer E.R. Squibb & Sons, L.L.C. Teva Neuroscience, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription